NESTLé HEALTH SCIENCE
Nestlé Health Science began operations on January 1, 2011. As a wholly-owned subsidiary of Nestlé, with global headquarters in Vevey, Switzerland, Nestlé Health Science has a distinct role to play in the Nestlé’s transformation into the world’s recognised leader in Nutrition, Health and Wellness. At Nestlé Health Science, their specific quest is to become the global leader in science-based personalised nutritional solutions. Nestlé Health Science has been established to pioneer sc... ience-based nutritional solutions in order to deliver improved personalised healthcare for medical conditions. In the longer term, the company aims to use nutritional solutions to change the healthcare paradigm and deliver affordable and effective health benefits which are also safe and sustainable. The company intends to use Nestlé's existing HealthCare Nutrition business to build a leading health science nutrition organisation within two years. It aims to develop a product portfolio and pipeline within five years and establish market leadership, meeting its vision, within a decade from start-up. The company has access to external scientific and technological know-how through Nestlés innovation network as well as a number of venture capital funds in which the group has interests.
NESTLé HEALTH SCIENCE
Industry:
Health Care
Founded:
2011-01-01
Address:
Vevey, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.nestlehealthscience.com
Total Employee:
1001+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Nginx
Similar Organizations
Axial Exchange
Axial Exchange delivers a remote patient/population health monitoring and communications platform.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-24 | Puravida | Puravida acquired by Nestlé Health Science | N/A |
| 2022-02-02 | Orgain | Orgain acquired by Nestlé Health Science | N/A |
| 2020-08-31 | Aimmune Therapeutics | Aimmune Therapeutics acquired by Nestlé Health Science | 2.6 B USD |
| 2020-08-18 | IM HealthScience | IM HealthScience acquired by Nestlé Health Science | N/A |
| 2020-06-10 | Vital Proteins | Vital Proteins acquired by Nestlé Health Science | N/A |
| 2019-08-22 | Persona | Persona acquired by Nestlé Health Science | N/A |
| 2016-09-02 | Phagenesis | Phagenesis acquired by Nestlé Health Science | N/A |
| 2011-05-24 | Prometheus Biosciences | Prometheus Biosciences acquired by Nestlé Health Science | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-13 | ProciseDx | Nestlé Health Science investment in Convertible Note - ProciseDx | 13 M USD |
| 2020-06-25 | ENTEROME | Nestlé Health Science investment in Series E - ENTEROME | 46.3 M EUR |
| 2020-02-05 | Aimmune Therapeutics | Nestlé Health Science investment in Post-IPO Equity - Aimmune Therapeutics | 200 M USD |
| 2019-04-02 | Amazentis | Nestlé Health Science investment in Venture Round - Amazentis | N/A |
| 2018-11-18 | Aimmune Therapeutics | Nestlé Health Science investment in Post-IPO Equity - Aimmune Therapeutics | 98 M USD |
| 2018-11-01 | Axcella | Nestlé Health Science investment in Series E - Axcella | 59 M USD |
| 2018-01-04 | ENTEROME | Nestlé Health Science investment in Debt Financing - ENTEROME | N/A |
| 2017-01-01 | ENTEROME | Nestlé Health Science investment in Series D - ENTEROME | 31.7 M EUR |
| 2016-11-04 | Aimmune Therapeutics | Nestlé Health Science investment in Post-IPO Equity - Aimmune Therapeutics | 145 M USD |
| 2016-04-20 | ENTEROME | Nestlé Health Science investment in Series C - ENTEROME | 14.5 M EUR |
Official Site Inspections
http://www.nestlehealthscience.com Semrush global rank: 1.01 M Semrush visits lastest month: 33.92 K
- Host name: 151.101.2.133
- IP address: 151.101.2.133
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
